Evidence map›Paper›PMID 31551400›Full record

ArticlemSystems2019

Nipah Virus-Like Particle Egress Is Modulated by Cytoskeletal and Vesicular Trafficking Pathways: a Validated Particle Proteomics Analysis.

Gunner P Johnston, Birgit Bradel-Tretheway, Paul D Piehowski, Heather M Brewer, Bom Nae Rin Lee, Nicholas T Usher, J Lizbeth Reyes Zamora, Victoria Ortega, Erik M Contreras, Jeremy R Teuton and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. NAADP-binding proteins find their identity.Trends in biochemical sciences · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Gunner P JohnstonDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Birgit Bradel-TrethewayPaul G. Allen Center for Global Animal Health, Washington State University, Pullman, Washington, USA.
Paul D PiehowskiPacific Northwest National Laboratories, Richland, Washington, USA.
Heather M BrewerPacific Northwest National Laboratories, Richland, Washington, USA.
Bom Nae Rin LeeDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Nicholas T UsherDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
J Lizbeth Reyes ZamoraDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Victoria OrtegaDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Erik M ContrerasDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Jeremy R TeutonPacific Northwest National Laboratories, Richland, Washington, USA.
Jason P WendlerPacific Northwest National Laboratories, Richland, Washington, USA.
Keesha M MatzPaul G. Allen Center for Global Animal Health, Washington State University, Pullman, Washington, USA.
Joshua N AdkinsPacific Northwest National Laboratories, Richland, Washington, USA joshua.adkins@pnnl.gov ha363@cornell.edu.
Hector C AguilarDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA joshua.adkins@pnnl.gov ha363@cornell.edu.
Cornell University · USPacific Northwest National Laboratory · USWashington State University · US

Funding

Mechanisms of Nipah virus fusion and entryR01AI109022 · NIAID · WASHINGTON STATE UNIVERSITY · PI AGUILAR-CARRENO, HECTOR · 2014 to 2024
$4.3M
NIAID NIH HHS R01 AI109022
6 · The paper itself

Abstract

Classified as a biosafety level 4 (BSL4) select agent, Nipah virus (NiV) is a deadly henipavirus in the

Indexed as

cytoskeletonendocytosishost-pathogen interactionNipah virusparamyxovirusproteomicsvesicular trafficking

Identifiers

PMID31551400
PMCPMC6759566
OpenAlexW2976360251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.